megestrol has been researched along with medrogestone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohorn, EI | 1 |
| Decker, DG; Edmonson, JH; Jefferies, JA; Malkasian, GD; O'Brien, PC; Podratz, KC | 1 |
| Rozier, JC; Underwood, PB | 1 |
| Hauri, D; Schoenenberger, A | 1 |
1 review(s) available for megestrol and medrogestone
| Article | Year |
|---|---|
[Conservative treatment of benign prostatic hyperplasia (author's transl)].
Topics: Adrenergic alpha-Antagonists; Bromocriptine; Cyproterone; Gestonorone Caproate; Humans; Male; Medrogestone; Megestrol; Plant Extracts; Polyenes; Prostatic Hyperplasia; Spironolactone; Tamoxifen | 1982 |
3 other study(ies) available for megestrol and medrogestone
| Article | Year |
|---|---|
Gestagens and endometrial carcinoma.
Topics: Female; Humans; Hydroxyprogesterones; Medrogestone; Medroxyprogesterone; Megestrol; Progesterone; Progestins; Uterine Neoplasms | 1976 |
Effects of progestational agents in treatment of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Medrogestone; Megestrol; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Time Factors; Uterine Neoplasms | 1985 |
Use of progestational agents in endometrial adenocarcinoma.
Topics: Adenocarcinoma; Administration, Oral; Endometrium; Female; Humans; Injections, Intramuscular; Medrogestone; Medroxyprogesterone; Megestrol; Neoplasm Metastasis; Neoplasm Recurrence, Local; Progestins; Uterine Neoplasms | 1974 |